Sundaram Multi Pap Schedules Board Meeting on May 25, 2026 to Approve Q4 and FY26 Audited Results

1 min read     Updated on 15 May 2026, 01:39 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Sundaram Multi Pap has announced a Board of Directors meeting on May 25, 2026, at 3.30 P.M. at its Mumbai registered office to approve audited standalone financial results for the quarter and financial year ended March 31, 2026. The agenda also includes consideration of the Independent Auditor's Report for the same period. The trading window for designated persons and their immediate relatives remains closed from April 01, 2026, until 48 hours after the results are declared.

powered bylight_fuzz_icon
40378124

*this image is generated using AI for illustrative purposes only.

Sundaram Multi Pap has notified the stock exchanges of an upcoming Board of Directors meeting, pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled to be held on Monday, May 25, 2026, at 3.30 P.M. at the company's registered office located at 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai 400093.

Meeting Agenda

The board meeting has been convened to deliberate upon and approve key financial matters. The following items are on the agenda:

Agenda Item: Details
Financial Results: Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026
Auditor's Report: Independent Auditor's Report issued by the Statutory Auditor for the quarter and financial year ended March 31, 2026
Other Business: Any other business with the permission of the Chairman

Trading Window Closure

In accordance with applicable SEBI regulations, Sundaram Multi Pap has also communicated the closure of the trading window for dealing or trading in the securities of the company. The trading window is closed with effect from April 01, 2026, and will remain closed until 48 hours after the declaration of the audited standalone financial results. This restriction applies to Promoters, Directors, Key Managerial Personnel (KMPs), Designated Personnel, and their immediate relatives.

The intimation was signed by Urmi Shah, Company Secretary and Compliance Officer (Membership No: A70885), and filed with both BSE Limited and the National Stock Exchange of India Ltd. on May 15, 2026.

Historical Stock Returns for Sundaram Multi Pap

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+1.45%-2.78%-25.13%-35.19%-9.68%

How might Sundaram Multi Pap's FY2026 audited results compare to the previous year's financial performance in terms of revenue growth and profitability?

Will the board consider announcing a dividend or any capital allocation strategy alongside the financial results declaration on May 25, 2026?

How could the release of Sundaram Multi Pap's audited standalone results impact its stock price and trading volumes once the trading window reopens?

Sundaram Multi Pap Expands Pan-India Sales Footprint

2 min read     Updated on 14 May 2026, 01:47 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Sundaram Multi Pap Limited announced a pan-India expansion of its sales operations, onboarding distributors across Tier II and Tier III cities. The company aims to double its sales points and increase its retail footprint by over 40% in the coming years while introducing new product lines.

powered bylight_fuzz_icon
40292257

*this image is generated using AI for illustrative purposes only.

sundaram multi pap has announced the pan-India expansion of its sales operations under the Sundaram Books brand. This strategic initiative aims to strengthen the company's presence across urban and rural markets by making quality stationery products accessible throughout the country. The expansion follows a period of testing the company's pan-India distribution capabilities.

The company has onboarded new distributors and stockists across Tier II and Tier III cities, expanding its coverage to multiple districts nationwide. This move is designed to cater to the growing demand for branded educational supplies in both organized retail and general trade channels. With the addition of new dealers and retailers, Sundaram Multi Pap Limited aims to double its sales points in the coming years.

Key Highlights of the Expansion

The expansion focuses on two primary areas to drive growth and market penetration:

  • Wider Distribution Network: The company has significantly increased its reach by adding partners in Tier II and Tier III cities.
  • Educational Partnerships: Sundaram is deepening engagement with educational institutions through customized notebooks, branding collaborations, and bulk procurement solutions.

Leadership Commentary

Mr. Krunal Shah, Director at Sundaram Multi Pap Ltd., described the expansion as a pivotal milestone in the company's journey. He stated that the initiative is focused on enabling learning, productivity, and creativity across India by ensuring access to quality stationery for every student and professional.

Future Outlook

Looking ahead, Sundaram aims to grow its retail footprint by over 40% in the coming years. The company plans to introduce several new product lines tailored to the evolving needs of students and offices. Additionally, Sundaram remains committed to sustainable manufacturing practices, continuing its use of eco-friendly paper and recyclable materials.

Historical Stock Returns for Sundaram Multi Pap

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+1.45%-2.78%-25.13%-35.19%-9.68%

How might Sundaram Multi Pap's pan-India expansion impact its revenue growth trajectory and market share relative to established national stationery competitors like Navneet Education and Classmate?

Will the company's digital education initiatives in Maharashtra be integrated into its Tier II and Tier III city expansion strategy to create a hybrid physical-digital product offering?

What financing mechanisms or capital allocation strategies is Sundaram Multi Pap likely to employ to fund the doubling of its sales points without straining its balance sheet?

More News on Sundaram Multi Pap

1 Year Returns:-35.19%